Randomized Clinical Trial to Evaluate the Predictability of 5.5 mm Dental Implants
Not Applicable
Completed
- Conditions
- Partial-edentulism
- Registration Number
- NCT04929743
- Lead Sponsor
- Fundación Eduardo Anitua
- Brief Summary
The main aim of this clinical trial is to analyze the survival rate of short-length implants (\<4.5 mm) in partial edentulism subjects. 6.5 mm length implants will be used as control arm. Additionally, others clinical parameters (marginal bone loss and prosthetic associated complications) will be measured.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
- Age ≥ 18 years
- Clinical indication to place a prosthetic bridge supported by a maximum of 4 implants in the posterior sectors
- Bone height in the area of interest sufficient to place implants 6.5mm length dental implants
- Availability to be observed during the follow-up period
- Signature of the informed consent
Exclusion Criteria
- Need to perform bone augmentation surgery prior to implant placement surgery
- Smokers (> 10 cigarettes per day)
- Patients with poorly controlled diabetes
- Patients on chronic treatment with non-steroidal anti-inflammatory drugs
- Patients receiving oral or intravenous bisphosphonates
- Patients under chemotherapy or radiotherapy treatment
- Patients receiving systemic corticosteroids
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Survival of implants 1 year Survival of implants at one year post-implantation
- Secondary Outcome Measures
Name Time Method Incidence of bleeding on probing 1 year Marginal bone loss 1 year Marginal bone loss at one year post-implantation
Probing pocket depth 1 year Incidence of prosthetic or implant complications 1 year
Trial Locations
- Locations (1)
Clinica Eduardo Anitua
🇪🇸Vitoria, Spain
Clinica Eduardo Anitua🇪🇸Vitoria, Spain